Company News
Xinkang Biotech Launches Comprehensive Solution for Foot-Spine Centers: Backed by Experience from Over 200 Hospitals, Driving Multidimensional Department Upgrades
Hangzhou, July 28, 2025—Xinkang Biomedical Technology (Hangzhou) Co., Ltd. (hereinafter referred to as "Xinkang Biotech") announced today the official launch of its "Comprehensive Solution for Foot-Spine Center Development," leveraging its extensive experience in deep departmental construction across more than 200 hospitals nationwide.
Chipcare Biomed Completes Scoliosis Screening for 300,000 Teenagers Nationwide
By integrating health education, early warning, comprehensive intervention and continuous follow-up, the company has established a sustainable prevention and control system that is injecting fresh momentum into the nation’s adolescent spinal-health initiative.
Xinkang Helps Rehabilitation Frontiers, Promotes Standardisation in the Scoliosis Rehabilitation Industry
Xinkang Medical Biotechnology Co., Ltd. and West China Rehabilitation Medical Center successfully held the Fifth Spinal Scoliosis and Posture Rehabilitation Training Course in Chengdu, China on June 27, 2025.